A detailed history of Washington Trust CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Washington Trust CO holds 19,292 shares of LLY stock, worth $16.8 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares
19,292
Previous 19,459 0.86%
Holding current value
$16.8 Million
Previous $17.2 Million 13.61%
% of portfolio
0.54%
Previous 0.61%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 30, 2025

SELL
$727.2 - $932.06 $121,442 - $155,654
-167 Reduced 0.86%
19,292 $14.9 Million
Q3 2024

Oct 25, 2024

BUY
$772.14 - $960.02 $75,669 - $94,081
98 Added 0.51%
19,459 $17.2 Million
Q2 2024

Jul 15, 2024

SELL
$724.87 - $909.04 $87,709 - $109,993
-121 Reduced 0.62%
19,361 $17.5 Million
Q1 2024

Apr 23, 2024

BUY
$592.2 - $792.28 $349,398 - $467,445
590 Added 3.12%
19,482 $15.2 Million
Q4 2023

Jan 18, 2024

BUY
$525.19 - $619.13 $1.4 Million - $1.65 Million
2,671 Added 16.47%
18,892 $11 Million
Q3 2023

Oct 18, 2023

BUY
$434.7 - $599.3 $5.62 Million - $7.74 Million
12,922 Added 391.69%
16,221 $8.71 Million
Q2 2023

Jul 27, 2023

SELL
$350.74 - $468.98 $9,469 - $12,662
-27 Reduced 0.81%
3,299 $1.55 Million
Q1 2023

May 10, 2023

BUY
$310.63 - $364.82 $1.04 Million - $1.23 Million
3,361 Added 112033.33%
3,364 $1.16 Million
Q1 2023

May 04, 2023

SELL
$310.63 - $364.82 $1.03 Million - $1.21 Million
-3,323 Reduced 99.91%
3 $1.16 Million
Q4 2022

Jul 27, 2023

SELL
$321.55 - $374.67 $12,218 - $14,237
-38 Reduced 1.13%
3,326 $1.22 Million
Q4 2022

Feb 08, 2023

BUY
$321.55 - $374.67 $80,387 - $93,667
250 Added 8.13%
3,326 $1.22 Million
Q3 2022

Oct 14, 2022

BUY
$296.48 - $337.87 $44,472 - $50,680
150 Added 5.13%
3,076 $995,000
Q2 2022

Jul 25, 2022

SELL
$278.73 - $327.27 $6,968 - $8,181
-25 Reduced 0.85%
2,926 $949,000
Q4 2021

Feb 09, 2022

SELL
$224.85 - $279.04 $169,761 - $210,675
-755 Reduced 20.37%
2,951 $816,000
Q3 2021

Nov 09, 2021

BUY
$221.6 - $272.71 $66,480 - $81,813
300 Added 8.81%
3,706 $855,000
Q2 2021

Aug 05, 2021

BUY
$180.55 - $233.54 $18,055 - $23,354
100 Added 3.02%
3,406 $782,000
Q4 2020

Feb 09, 2021

SELL
$130.46 - $172.63 $13,046 - $17,263
-100 Reduced 2.94%
3,306 $558,000
Q3 2020

Nov 05, 2020

BUY
$146.22 - $169.13 $66,530 - $76,954
455 Added 15.42%
3,406 $504,000
Q2 2020

Aug 04, 2020

SELL
$136.42 - $164.18 $42,153 - $50,731
-309 Reduced 9.48%
2,951 $480,000
Q1 2020

May 07, 2020

BUY
$119.05 - $147.35 $388,103 - $480,361
3,260 New
3,260 $452,000
Q4 2019

Feb 12, 2020

SELL
$106.92 - $132.43 $222,714 - $275,851
-2,083 Closed
0 $0
Q3 2019

Nov 06, 2019

SELL
$106.79 - $116.16 $131,565 - $143,109
-1,232 Reduced 37.16%
2,083 $237,000
Q2 2019

Aug 07, 2019

BUY
$110.79 - $129.32 $367,268 - $428,695
3,315 New
3,315 $368,000
Q1 2019

May 13, 2019

SELL
$111.31 - $131.02 $298,310 - $351,133
-2,680 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$85.86 - $107.31 $81,309 - $101,622
-947 Reduced 26.11%
2,680 $288,000
Q2 2018

Aug 10, 2018

SELL
$75.7 - $86.88 $11,582 - $13,292
-153 Reduced 4.05%
3,627 $309,000
Q4 2017

Feb 05, 2018

SELL
$81.94 - $87.89 $11,225 - $12,040
-137 Reduced 3.5%
3,780 $320,000
Q3 2017

Oct 31, 2017

BUY
$77.07 - $85.54 $301,883 - $335,060
3,917
3,917 $335,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $826B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Washington Trust CO Portfolio

Follow Washington Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Washington Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Washington Trust CO with notifications on news.